Union Minister of State Jitendra Singh envisioned a biotech-powered future for India while inaugurating key facilities at the Akkulam campus of BRIC-Rajiv Gandhi Centre for Biotechnology. On Saturday, after laying the foundation for a cutting-edge cGMP plant, he articulated how the BioE3 policy embodies a strategic vision placing biotechnology central to national growth.
Amid recent policy liberalizations, Singh focused on the expanding frontiers of nuclear medicine. He appealed for cross-disciplinary ties between public R&D and industry, powered by the Nuclear Medical Mission to spur translational breakthroughs.
Singh commissioned the National Facility for Recombinant Cells and Sensors and opened the campus’s Science Day event. He lauded BioE3—India’s unique policy integrating biotech with economy, ecology, and employment—for promoting green innovation and sustainable models.
Invoking the Biopharma Shakti Mission, the minister observed the global economy’s bio-shift, backed by a decade of prioritized science funding. BRIC-RGCB stands out with prowess in genomics, molecular studies, disease biology, and cancer, magnetizing researchers for bioinformatics and sequencing expertise.
Biotech Secretary Dr. Rajesh Gokhale called the sector pivotal for progress, detailing BioE3’s six themes like bio-manufacturing and the use of RGCB data in HPV vaccinations. Director Dr. T.R. Santhosh Kumar shared that their cell facility boasts 600-700 lines targeting cancer pathways, a global hub, with cGMP enabling economical gene therapies for wider reach.